Loading…
Based on limited metadata, this warning letter was issued to Lotus Herbal Supplements on July 6, 2020, regarding products classified as drugs. Without access to the full letter text or subject line, the specific nature of the violations cannot be determined from the available information. The warning falls under FDA drug regulatory authority, though the specific issuing office is not identified in the metadata provided. To understand the detailed violations and required corrective actions, the complete warning letter would need to be reviewed.